Gilead Sciences Inc option shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Gilead Sciences Inc option shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Gilead Sciences Inc option
Tip: Access up to 7 years of quarterly data
All positions including Gilead Sciences Inc option held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gilead Sciences Inc option by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $30M | 273k | 111.00 |
| 2025-03-31 | $5.8M | 52k | 112.05 |
| 2024-12-31 | $8.1M | 87k | 92.37 |
| 2024-09-30 | $12M | 147k | 83.84 |
| 2024-06-30 | $3.9M | 56k | 68.61 |
| 2024-03-31 | $4.6M | 63k | 73.25 |
| 2023-12-31 | $18M | 227k | 81.01 |
| 2023-09-30 | $18M | 243k | 74.94 |
| 2023-06-30 | $12M | 153k | 77.07 |
| 2023-03-31 | $34M | 404k | 82.97 |
| 2022-12-31 | $58M | 679k | 85.85 |
| 2022-06-30 | $27M | 442k | 61.81 |
| 2022-03-31 | $15M | 254k | 59.45 |
| 2021-12-31 | $47M | 646k | 72.61 |
| 2021-03-31 | $13M | 200k | 64.63 |
| 2020-12-31 | $39M | 670k | 58.26 |
| 2020-09-30 | $40M | 648k | 62.10 |
| 2020-06-30 | $41M | 535k | 76.94 |
| 2020-03-31 | $47M | 627k | 74.76 |
| 2019-12-31 | $52M | 795k | 64.98 |
| 2019-09-30 | $37M | 578k | 63.38 |
| 2019-06-30 | $18M | 263k | 67.08 |
| 2019-03-31 | $30M | 454k | 65.01 |
| 2018-12-31 | $30M | 482k | 62.55 |
| 2018-09-30 | $40M | 512k | 77.21 |
| 2018-06-30 | $33M | 459k | 70.84 |
| 2018-03-31 | $24M | 312k | 75.39 |
| 2017-12-31 | $64M | 894k | 71.64 |
| 2017-06-30 | $54M | 760k | 70.78 |
| 2017-03-31 | $38M | 563k | 67.92 |
| 2016-12-31 | $43M | 601k | 71.61 |
| 2016-09-30 | $19M | 242k | 79.12 |
| 2016-06-30 | $12M | 141k | 83.42 |
| 2016-03-31 | $7.8M | 85k | 91.86 |
| 2015-12-31 | $125M | 1.2M | 101.19 |
| 2015-09-30 | $111M | 1.1M | 98.19 |
Top funds holding Gilead Sciences Inc option
View all funds holding Gilead Sciences Inc option